Search

everythinglearnresearchcommunity

for

Search:↓

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Clofazimine may be effective for treating ashy dermatosis.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Amoxapine may be effective for treating ejaculatory dysfunction.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Baricitinib is a promising treatment for alopecia areata.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Valproic acid can cause reversible hair curling and persistent hair thinning.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.